Apr 10, 2025

WCO-IOF-ESCEO

Abstract

OSTEO

Cost-Effectiveness of Opportunistic Osteoporosis Screening using Chest Radiographs with Deep Learning in Germany

Hiligsmann M1, Schmidmaier R 2, Reginster JY 3 1 Maastricht University, the Netherlands ² LMU Munich, München, Germany ³ King Saud University, Riyadh, Kingdom of Saudi Arabia

Objective(s): Deep learning models applied to chest radiographs can support opportunistic osteoporosis screening. This study evaluates the cost-effectiveness of this approach in German women aged 50 years and over.

Materials and Methods: A microsimulation Markov model estimated the cost per quality-adjusted life year (QALY) gained (€2024) for screening via chest radiographs with deep learning, followed by treatment, versus no screening and treatment. The patient pathways were based on the sensitivity and specificity of AI-enhanced radiographs and risk stratification per German osteoporosis guidelines. Women with a fracture risk below 5% received no treatment; those with 5–10% risk were prescribed alendronate, and those aged 65+ with risk >10% received sequential treatment starting with romosozumab. Assumptions and data were validated by a German clinical expert. Real-world medication persistence, realistic assumptions for probabilities of DXA examination post-screening detection and for treatment initiation rates were incorporated. Parameter uncertainty was analyzed through sensitivity analyses.

Results: Screening improved health outcomes, yielding more QALYs and fewer fractures while increasing treatment costs. The cost per QALY gained of opportunistic screening was estimated at €13,340 for all women aged 50+, well below the commonly accepted cost-effectiveness thresholds, which are generally in the range of €60,000. Optimizing follow-up, treatment initiation, and adherence enhanced cost-effectiveness, with dominance (higher QALYs at lower costs) achievable by halving medication non-persistence.

Conclusion(s): Opportunistic osteoporosis screening using chest radiographs with deep learning is a cost-effective strategy for German women aged 50 and older under real-world conditions. Improving screening follow-up and medication adherence could further enhance cost-effectiveness and achieve dominance.

Acknowledgments: This study was funded by an unrestricted educational grant from Promedius.

프로메디우스 주식회사.

Copyright 2025 PROMEDIUS INC. All rights reserved.

05510 서울특별시 송파구 올림픽로35다길 13, 국민연금 잠실사옥 4층(신천동)

프로메디우스 주식회사.

Copyright 2025 PROMEDIUS INC. All rights reserved.

05510 서울특별시 송파구 올림픽로35다길 13, 국민연금 잠실사옥 4층(신천동)